Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
DGX Quest Diagnostics	$178.39 -0.1%	$169.31	$135.27 ▼ $179.16	$19.91B	0.78	962,285 shs	1.62 million shs
DVA DaVita	$141.72 +0.1%	$146.11	$131.27 ▼ $179.60	$11.34B	1.04	838,377 shs	744,009 shs
LDR Landauer	$67.20	$0.00	$41.00 ▼ $68.50	N/A	N/A	56,169 shs	N/A
LH Laboratory Co. of America	$240.87 +0.2%	$234.59	$191.97 ▼ $258.59	$20.15B	0.99	637,505 shs	987,067 shs

Elon Musk's Next Move

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
DGX Quest Diagnostics	-0.29%	+2.64%	+5.31%	+8.80%	+29.10%
DVA DaVita	+0.19%	+1.90%	-7.48%	-19.76%	+1.95%
LDR Landauer	0.00%	0.00%	0.00%	0.00%	0.00%
LH Laboratory Co. of America	+0.29%	+7.42%	+3.47%	-4.18%	+19.62%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
DGX Quest Diagnostics	4.5578 of 5 stars	2.3	3.0	4.2	4.7	2.6	2.5	1.3
DVA DaVita	4.2903 of 5 stars	2.0	3.0	0.0	4.5	3.0	1.7	3.1
LDR Landauer	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
LH Laboratory Co. of America	4.719 of 5 stars	3.4	3.0	2.5	4.2	3.3	2.5	1.3

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
DGX Quest Diagnostics	2.69	Moderate Buy	$185.07	3.74% Upside
DVA DaVita	2.00	Hold	$166.33	17.37% Upside
LDR Landauer	0.00	N/A	N/A	N/A
LH Laboratory Co. of America	2.87	Moderate Buy	$267.85	11.20% Upside

Current Analyst Ratings Breakdown

Latest LDR, DGX, LH, and DVA Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
4/30/2025	LH Laboratory Co. of America	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Equal Weight ➝ Equal Weight	$240.00 ➝ $250.00
4/30/2025	LH Laboratory Co. of America	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform ➝ Outperform	$253.00 ➝ $267.00
4/28/2025	DGX Quest Diagnostics	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Neutral ➝ Neutral	$180.00 ➝ $200.00
4/23/2025	DGX Quest Diagnostics	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Hold ➝ Hold	$182.00 ➝ $190.00
4/23/2025	DGX Quest Diagnostics	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	In-Line ➝ In-Line	$175.00 ➝ $180.00
4/23/2025	DGX Quest Diagnostics	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Equal Weight ➝ Equal Weight	$175.00 ➝ $185.00
4/23/2025	DGX Quest Diagnostics	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform ➝ Outperform	$191.00 ➝ $194.00
4/11/2025	LH Laboratory Co. of America	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$285.00 ➝ $274.00
4/10/2025	LH Laboratory Co. of America	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Equal Weight ➝ Equal Weight	$260.00 ➝ $240.00
4/9/2025	DGX Quest Diagnostics	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform ➝ Outperform	$178.00 ➝ $189.00
4/2/2025	DGX Quest Diagnostics	Redburn Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target		$195.00

(Data available from 5/1/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
DGX Quest Diagnostics	$10.16B	1.96	$13.91 per share	12.82	$61.04 per share	2.92
DVA DaVita	$12.82B	0.88	$18.57 per share	7.63	$4.95 per share	28.63
LDR Landauer	N/A	N/A	N/A	N/A	N/A	N/A
LH Laboratory Co. of America	$13.01B	1.55	$21.72 per share	11.09	$96.27 per share	2.50

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
DGX Quest Diagnostics	$871M	$7.91	23.20	17.01	2.16	8.80%	15.07%	6.72%	N/A
DVA DaVita	$936.34M	$10.74	13.20	11.15	1.07	7.31%	115.48%	4.94%	5/1/2025 (Estimated)
LDR Landauer	N/A	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A
LH Laboratory Co. of America	$746M	$8.82	27.31	13.73	1.71	5.73%	15.29%	7.01%	N/A

Latest LDR, DGX, LH, and DVA Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
5/1/2025	Q1 2025	DVA DaVita	$1.75	N/A	N/A	N/A	$3.22 billion	N/A
4/29/2025	Q1 2025	LH Laboratory Co. of America	$3.73	$3.84	+$0.11	$2.52	$3.41 billion	$3.35 billion
4/22/2025	Q1 2025	DGX Quest Diagnostics	$2.15	$2.21	+$0.06	$1.94	$2.63 billion	$2.65 billion
2/13/2025	Q4 2024	DVA DaVita	$2.14	$2.24	+$0.10	$3.09	$3.27 billion	N/A
2/6/2025	Q4 2024	LH Laboratory Co. of America	$3.40	$3.45	+$0.05	$1.70	$3.31 billion	N/A

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
DGX Quest Diagnostics	$3.20	1.79%	+6.94%	40.46%	14 Years
DVA DaVita	N/A	N/A	N/A	N/A	N/A
LDR Landauer	$1.10	1.64%	N/A	N/A	N/A
LH Laboratory Co. of America	$2.88	1.20%	N/A	32.65%	N/A

Latest LDR, DGX, LH, and DVA Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
4/10/2025	LH Laboratory Co. of America	quarterly	$0.72	1.25%		5/29/2025	6/11/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
DGX Quest Diagnostics	0.82	1.10	1.02
DVA DaVita	23.18	1.26	1.21
LDR Landauer	N/A	N/A	N/A
LH Laboratory Co. of America	0.67	1.44	1.30

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
DGX Quest Diagnostics	88.06%
DVA DaVita	90.12%
LDR Landauer	79.56%
LH Laboratory Co. of America	95.94%

Insider Ownership

Company	Insider Ownership
DGX Quest Diagnostics	8.16%
DVA DaVita	2.00%
LDR Landauer	6.60%
LH Laboratory Co. of America	0.84%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
DGX Quest Diagnostics	49,000	111.64 million	110.73 million	Optionable
DVA DaVita	70,000	80.00 million	78.40 million	Optionable
LDR Landauer	N/A	N/A	N/A	Not Optionable
LH Laboratory Co. of America	75,500	83.67 million	82.93 million	Optionable

LDR, DGX, LH, and DVA Headlines

Recent News About These Companies

Laboratory Corporation of America Holdings (NYSE:LH) Q1 2025 Earnings Call Transcript

April 30 at 6:20 PM | msn.com

Earnest Partners LLC Sells 8,355 Shares of Laboratory Co. of America Holdings (NYSE:LH)

April 30 at 6:51 AM | marketbeat.com

Adage Capital Partners GP L.L.C. Acquires Shares of 42,644 Laboratory Co. of America Holdings (NYSE:LH)

April 30 at 5:31 AM | marketbeat.com

Labcorp (NYSE:LH) Reports Sales Below Analyst Estimates In Q1 Earnings

April 29 at 11:44 AM | finance.yahoo.com

Labcorp (LH) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

April 29 at 10:35 AM | zacks.com

Labcorp Q1 Earnings Surpass Estimates, Revenues Miss, Stock Gains

April 29 at 9:56 AM | zacks.com

Labcorp (LH) Beats Q1 Earnings Estimates

April 29 at 9:01 AM | zacks.com

Labcorp Announces 2025 First Quarter Results

April 29 at 7:04 AM | prnewswire.com

Labcorp beats quarterly profit estimate on diagnostic test demand

April 29 at 6:56 AM | reuters.com

First Trust Advisors LP Raises Position in Laboratory Co. of America Holdings (NYSE:LH)

April 29 at 4:28 AM | marketbeat.com

6LH : Earnings Preview: Laboratory Corp

April 28 at 2:58 PM | benzinga.com

Fuller & Thaler Asset Management Inc. Grows Stock Holdings in Laboratory Co. of America Holdings (NYSE:LH)

April 28 at 5:27 AM | marketbeat.com

Hsbc Holdings PLC Has $37.18 Million Stake in Laboratory Co. of America Holdings (NYSE:LH)

April 28 at 5:07 AM | marketbeat.com

Labcorp (LH) Reports Q1: Everything You Need To Know Ahead Of Earnings

April 28 at 4:56 AM | finance.yahoo.com

State of Tennessee Department of Treasury Purchases 5,454 Shares of Laboratory Co. of America Holdings (NYSE:LH)

April 28 at 4:46 AM | marketbeat.com

Lord Abbett & CO. LLC Sells 126,638 Shares of Laboratory Co. of America Holdings (NYSE:LH)

April 27, 2025 | marketbeat.com

Laboratory Co. of America Holdings (NYSE:LH) Holdings Decreased by BI Asset Management Fondsmaeglerselskab A S

April 27, 2025 | marketbeat.com

Analysts Set Laboratory Co. of America Holdings (NYSE:LH) Target Price at $268.77

April 27, 2025 | americanbankingnews.com

Laboratory Co. of America Holdings (NYSE:LH) Position Trimmed by J. Safra Sarasin Holding AG

April 26, 2025 | marketbeat.com

Laboratory Co. of America Holdings (NYSE:LH) Shares Acquired by Natixis

April 26, 2025 | marketbeat.com

NewEdge Advisors LLC Increases Stock Position in Laboratory Co. of America Holdings (NYSE:LH)

April 26, 2025 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

LDR, DGX, LH, and DVA Company Descriptions

Quest Diagnostics NYSE:DGX

$178.39 -0.11 (-0.06%)

As of 04/30/2025 03:59 PM Eastern

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

DaVita NYSE:DVA

$141.72 +0.18 (+0.13%)

As of 04/30/2025 03:59 PM Eastern

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.

Landauer NYSE:LDR

Landauer, Inc. is a provider of technical and analytical services to determine occupational and environmental radiation exposure. The Company is a provider of outsourced medical physics services, and a provider of radiology related medical products. The Company operates through three segments: Radiation Measurement, Medical Physics and Medical Products. The Company provides radiation dosimetry services to hospitals, medical and dental offices, universities, national laboratories, nuclear facilities and other industries. Medical physics services are provided through the Company's Landauer Medical Physics (LMP) division. The Company uses LMP as a platform to expand into the medical physics services market, serving domestic hospitals, radiation therapy centers and imaging centers. The Company's Medical Products segment provides medical consumable accessories used in radiology, radiation therapy and image guided surgery procedures.

Laboratory Co. of America NYSE:LH

$240.87 +0.45 (+0.19%)

As of 04/30/2025 03:59 PM Eastern

Labcorp Holdings, Inc. engages in providing medical testing services. The company was founded on April 16, 2024 and is headquartered in Burlington, NC.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time